NASDAQ:DH Definitive Healthcare (DH) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free DH Stock Alerts $6.73 -0.52 (-7.17%) (As of 05:12 PM ET) Add Compare Share Share Today's Range$6.66▼$7.1450-Day Range$7.04▼$10.2652-Week Range$5.53▼$12.45Volume384,340 shsAverage Volume582,302 shsMarket Capitalization$792.73 millionP/E RatioN/ADividend YieldN/APrice Target$11.31 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Definitive Healthcare alerts: Email Address Definitive Healthcare MarketRank™ Stock AnalysisAnalyst RatingHold2.22 Rating ScoreUpside/Downside68.1% Upside$11.31 Price TargetShort InterestBearish14.35% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.15Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth27.27%From $0.11 to $0.14 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.14 out of 5 starsMedical Sector427th out of 907 stocksPrepackaged Software Industry115th out of 194 stocks 3.1 Analyst's Opinion Consensus RatingDefinitive Healthcare has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 2 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageDefinitive Healthcare has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted14.35% of the float of Definitive Healthcare has been sold short.Short Interest Ratio / Days to CoverDefinitive Healthcare has a short interest ratio ("days to cover") of 13.4, which indicates bearish sentiment.Change versus previous monthShort interest in Definitive Healthcare has recently decreased by 6.18%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldDefinitive Healthcare does not currently pay a dividend.Dividend GrowthDefinitive Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DH. Previous Next 2.3 News and Social Media Coverage News SentimentDefinitive Healthcare has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for DH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Definitive Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders15.27% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Definitive Healthcare are expected to grow by 27.27% in the coming year, from $0.11 to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Definitive Healthcare is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Definitive Healthcare is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDefinitive Healthcare has a PEG Ratio of 6.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDefinitive Healthcare has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Definitive Healthcare Stock (NASDAQ:DH)Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.Read More DH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DH Stock News HeadlinesApril 23, 2024 | globenewswire.comDefinitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and WebcastApril 23, 2024 | americanbankingnews.comDefinitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of "Hold" by BrokeragesApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 16, 2024 | finance.yahoo.comDefinitive Healthcare introduces Carevoyance sales enablement solution for medtech industryMarch 22, 2024 | markets.businessinsider.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 22, 2024 | globenewswire.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 21, 2024 | markets.businessinsider.comNeedham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)March 20, 2024 | morningstar.comDefinitive Healthcare Corp Class AApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 19, 2024 | seekingalpha.comDefinitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25March 16, 2024 | finance.yahoo.comDH Apr 2024 5.000 putMarch 16, 2024 | finance.yahoo.comDH Jul 2024 5.000 putMarch 14, 2024 | globenewswire.comDefinitive Healthcare earns 2024 Middle Market Leader Award from Boston Business JournalMarch 2, 2024 | finance.yahoo.comDefinitive Healthcare Corp. (NASDAQ:DH) Just Released Its Annual Earnings: Here's What Analysts ThinkMarch 1, 2024 | markets.businessinsider.comHold Rating on Definitive Healthcare Amid Leadership Changes and Revenue UncertaintiesMarch 1, 2024 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About Definitive HealthcareFebruary 29, 2024 | markets.businessinsider.comMaintaining Hold on Definitive Healthcare Corp Amidst Transition and Mixed Growth SignalsFebruary 29, 2024 | markets.businessinsider.comChallenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 AnalysisFebruary 29, 2024 | finanznachrichten.deDefinitive Healthcare Corp.: Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023February 28, 2024 | seekingalpha.comDefinitive Healthcare Corp. 2023 Q4 - Results - Earnings Call PresentationFebruary 28, 2024 | msn.comDefinitive Healthcare reports Q4 resultsFebruary 28, 2024 | finance.yahoo.comDefinitive Healthcare Corp Reports Mixed Results Amidst Growth and ChallengesFebruary 28, 2024 | globenewswire.comDefinitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023February 27, 2024 | benzinga.comEarnings Outlook For Definitive HealthcareFebruary 17, 2024 | finance.yahoo.comDH Mar 2024 10.000 callFebruary 14, 2024 | finance.yahoo.comDefinitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and WebcastFebruary 14, 2024 | globenewswire.comDefinitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and WebcastSee More Headlines Receive DH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today4/25/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:DH CUSIPN/A CIK1861795 Webwww.definitivehc.com Phone508-720-4224FaxN/AEmployees950Year FoundedN/APrice Target and Rating Average Stock Price Target$11.31 High Stock Price Target$15.00 Low Stock Price Target$9.50 Potential Upside/Downside+64.9%Consensus RatingHold Rating Score (0-4)2.22 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.78) Trailing P/E RatioN/A Forward P/E Ratio62.36 P/E Growth6.33Net Income$-202,390,000.00 Net Margins-80.40% Pretax Margin-122.58% Return on Equity0.43% Return on Assets0.29% Debt Debt-to-Equity Ratio0.20 Current Ratio2.31 Quick Ratio2.31 Sales & Book Value Annual Sales$251.41 million Price / Sales3.21 Cash Flow$2.93 per share Price / Cash Flow2.34 Book Value$10.31 per share Price / Book0.67Miscellaneous Outstanding Shares117,790,000Free Float99,803,000Market Cap$808.04 million OptionableNot Optionable Beta1.39 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Jason Ronald Krantz (Age 50)Founder, Executive Chairman & Interim CEO Comp: $130.38kMr. Jonathan Maack (Age 45)President Comp: $687.21kMr. Richard Douglas Booth (Age 55)Chief Financial Officer Comp: $579.47kMs. Kate Marie Shamsuddin Jensen (Age 37)Chief Product Officer Comp: $431.86kMs. Carrie Lazorchak (Age 54)Chief Revenue Officer Comp: $110.49kMr. Scott OberlinkChief Technology OfficerMr. Matthew RudermanChief Legal Officer & SecretaryMr. Craig HazenfieldChief People OfficerMr. Ram SharmaExecutive Vice President of Life SciencesMore ExecutivesKey CompetitorsTuyaNYSE:TUYAExpensifyNASDAQ:EXFYLivePersonNASDAQ:LPSNEverCommerceNASDAQ:EVCMSemrushNASDAQ:SEMRView All CompetitorsInsiders & InstitutionsWesbanco Bank Inc.Bought 69,000 shares on 4/23/2024Ownership: 0.059%Raymond James & AssociatesBought 248,266 shares on 4/22/2024Ownership: 0.717%Berry Wealth Group LPBought 12,323 shares on 4/22/2024Ownership: 0.010%Norden Group LLCBought 10,245 shares on 4/19/2024Ownership: 0.009%Tower Research Capital LLC TRC Bought 4,959 shares on 2/13/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions DH Stock Analysis - Frequently Asked Questions Should I buy or sell Definitive Healthcare stock right now? 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares. View DH analyst ratings or view top-rated stocks. What is Definitive Healthcare's stock price target for 2024? 9 equities research analysts have issued 1 year target prices for Definitive Healthcare's shares. Their DH share price targets range from $9.50 to $15.00. On average, they expect the company's stock price to reach $11.31 in the next year. This suggests a possible upside of 68.1% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts. How have DH shares performed in 2024? Definitive Healthcare's stock was trading at $9.94 at the start of the year. Since then, DH shares have decreased by 32.3% and is now trading at $6.73. View the best growth stocks for 2024 here. Are investors shorting Definitive Healthcare? Definitive Healthcare saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 6,980,000 shares, a decline of 6.2% from the March 31st total of 7,440,000 shares. Based on an average trading volume of 522,800 shares, the short-interest ratio is currently 13.4 days. Currently, 14.4% of the company's stock are short sold. View Definitive Healthcare's Short Interest. When is Definitive Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our DH earnings forecast. How can I listen to Definitive Healthcare's earnings call? Definitive Healthcare will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 757-849-6722 with passcode "1765#". How were Definitive Healthcare's earnings last quarter? Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The business had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%. What ETFs hold Definitive Healthcare's stock? ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Definitive Healthcare issued on next quarter's earnings? Definitive Healthcare updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 0.070-0.080 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million. When did Definitive Healthcare IPO? Definitive Healthcare (DH) raised $350 million in an IPO on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share. Who are Definitive Healthcare's major shareholders? Definitive Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include Raymond James & Associates (0.72%), Wesbanco Bank Inc. (0.06%), Berry Wealth Group LP (0.01%) and Norden Group LLC (0.01%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc. View institutional ownership trends. How do I buy shares of Definitive Healthcare? Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
